Enhanced uptake of intra-arterially injected anti-CEA monoclonal antibodies in human colonic cancer after mannitol infusion in an experimental model.
In a previous report athymic rats carrying transplanted human colonic tumours from cell line LS 174T in both hind legs were injected intra-arterially (i.a.) with 125I-labelled anti-carcinoembryonic (anti-CEA) monoclonal antibodies. The i.a. injection was given on one side bearing a tumour in each rat, while the contralateral tumour served as an 'intravenous' control. In the same experimental model and treated in the same way, 10 rats were injected i.a. with anti-CEA monoclonal antibodies after an i.a. mannitol infusion. In both groups of rats external gamma measurements were performed daily for four days. On the fourth day the rats were killed and pieces of the tumours and of various organs were weighed and the activity was determined with a gamma-counter. The tumour uptake of antibodies was significantly enhanced after mannitol infusion.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000503:physiopathology; D002199:Capillary Permeability / Q000187:drug effects; D002272:Carcinoembryonic Antigen / Q000276:immunology*; D003110:Colonic Neoplasms / Q000378:metabolism*; D006801:Humans; D007269:Injections, Intra-Arterial; D008353:Mannitol / Q000494:pharmacology*; D051379:Mice; D009368:Neoplasm Transplantation; D051381:Rats; D014018:Tissue Distribution; D014183:Transplantation, Heterologous
D000911:Antibodies, Monoclonal; D002272:Carcinoembryonic Antigen; D008353:Mannitol